Ultra High Performance Liquid Chromatograph Nexera X4

Nexera X4 Ultra High Performance Liquid Chromatograph — Executive Summary

Significance of the Topic

The Nexera X4 represents a next-generation UHPLC platform intended to push analytical throughput, sensitivity, and robustness in modern laboratories. Minimizing extra-column band broadening, enabling reproducible ultra-fast gradients, and reducing solvent consumption are central to improving throughput for pharmaceutical, bioanalytical, and routine QC workflows while preserving or improving data quality. These advances address common bottlenecks in high-throughput analysis: peak dispersion, gradient fidelity at high pressure, and operational reliability in multi-operator environments.

Objectives and Overview of the System

This document describes the design features and measured performance of the Nexera X4 UHPLC system. Primary goals are to: reduce system-derived peak broadening to fully exploit modern UHPLC columns; deliver highly responsive, low-pulsation solvent gradients for ultra-fast separations; enable analytical miniaturization to cut solvent use; and integrate robust diagnostics and workflow tools to maximize uptime and reproducibility across operators.

Methodology and Key Design Features

The Nexera X4 achieves its objectives through a combination of hardware innovations and fluid control strategies:

• Nexflow low-dispersion fluid path design that reduces extra-column band broadening without increasing tubing internal diameter or length.
• LC-40B X4 solvent delivery unit with four independently actuated plungers and pressure feedback for reduced pulsation, fast gradient responsiveness, and stable baselines under high-pressure conditions.
• SSU-40 solvent switching and online degassing module enabling up to four solvent lines per pump for rapid method scouting and mobile phase changes.
• SPD-M40 X4 photodiode array (PDA) detector employing a low-volume capillary cell to reduce refractive index effects, extend dynamic range and improve baseline stability for both low- and high-concentration samples.
• SIL-40C X4 high-end autosampler with low-internal-volume high-pressure valve, low-dispersion injection mode, internal/external needle rinsing, and the Nexlock II sealing/fitting design to minimize dead volume and enable tool-free, high-pressure tolerant column connections.
• Integrated digital capabilities (Analytical Intelligence) for automated pre-run checks, continuous monitoring, and automated recovery to maintain data quality and reduce downtime.

Used Instrumentation

Primary system components described:

• System controller: SCL-40 with CBM-40/40lite
• Solvent switching and degassing unit: SSU-40
• PDA detector: SPD-M40 X4
• Solvent delivery/pump: LC-40B X4
• Autosampler: SIL-40C X4
• Column oven: CTO-40C
• Optional MS integration: LCMS-8060 series (triple quad) for fast polarity switching and high-sensitivity MS detection

Main Results and Discussion

Performance highlights reported for the Nexera X4 include:

• Substantially reduced extra-column dispersion leading to ultra-sharp peaks and improved theoretical plate numbers versus a typical UHPLC system. Reported relative improvements in theoretical plates for weakly retained components ranged from ~4% to 81% depending on peak.
• Marked increase in signal quality: an ECBB (extra-column band broadening) metric reported as low (7 µL) and improvements in signal-to-noise and full width at half maximum (FWHM) compared with typical UHPLC.
• Ultra-fast gradient capability: the LC-40B X4 pump and Nexflow design enable gradient analyses that are, on average, 92% faster than conventional HPLC and 78% faster than existing UHPLC-like systems in the examples provided — enabling up to a 14-fold increase in laboratory productivity for selected workflows.
• Exceptional gradient reproducibility under ultra-fast conditions: retention time %RSD reported as 0.006% (n=6) on Nexera X4 versus 0.277% for a typical UHPLC setup, demonstrating highly stable solvent delivery and retention time fidelity for short gradients.
• Reduced solvent consumption through analytical miniaturization: using narrow-bore columns (1.0 mm I.D.) and lower flow rates supports micro-injection (≤1 µL) and minute flow precision. Example solvent consumption over 800 analyses: ~7.7 L (3.0 mm I.D.), ~3.8 L (2.1 mm I.D.), and ~0.9 L (1.0 mm I.D.), highlighting substantial solvent savings with 1.0 mm columns.
• MS compatibility and enhanced LC–MS workflows: dedicated low-dispersion tubing kits for column-to-MS connections and pairing with LCMS-8060 series systems leverage UFswitching (5 ms polarity switching) to maintain ion intensity during rapid polarity changes. Demonstrated PK assay (eight anticoagulants in plasma) achieved total cycle times of ≈2.45 minutes with acceptable accuracy (96–109%) and precision (3–14% CV) at the stated LLOQ.

Benefits and Practical Applications

The Nexera X4 platform presents practical advantages across multiple analytical contexts:

• Pharmaceutical QC and impurity profiling: improved peak sharpness and theoretical plates enhance resolution of closely eluting impurities, enabling shorter run times without compromising separation quality.
• High-throughput bioanalysis and PK studies: ultra-fast, reproducible gradients combined with robust LC–MS integration reduce cycle times and increase sample throughput, supporting large studies with simple sample prep.
• Method development and scouting: SSU-40 solvent switching and responsive pumps accelerate method screening by quickly switching mobile phases and maintaining stable gradients.
• Cost and sustainability: narrow-bore miniaturization reduces solvent consumption and waste, lowering operating costs and environmental footprint.
• Routine laboratory operation: integrated Analytical Intelligence and automated system checks help maintain data integrity across operators and reduce downtime due to operational errors or degraded components.

Columns, Stationary Phase Options and Notes

Shimadzu column families highlighted for use with Nexera X4:

• Shim-pack NovaCore C18 series — core-shell (superficially porous) organic silica hybrid particles, optimized for fast separations of basic compounds with wide pH tolerance (usable pH 1–12, typical temp up to 60 °C with pH caveats) and low dispersion behavior.
• Shim-pack Scepter series — fully porous organic silica hybrid columns available in multiple chemistries (C18, C8, phenyl, PFPP, HILIC, etc.) and particle sizes optimized for UHPLC and narrow-bore formats (including 1.0 mm I.D. columns) to support solvent-saving miniaturized methods.

Future Trends and Potential Applications

Anticipated directions and opportunities for systems like the Nexera X4 include:

• Deeper integration with MS and automated data-dependent workflows to enable more automated, high-throughput quantitation and identification pipelines for drug discovery and clinical studies.
• Further miniaturization toward micro- and nano-LC applications, driven by continued improvements in low-dispersion fluidics and micro-injection precision, to reduce sample and solvent needs for scarce or expensive analytes.
• Expanded use of embedded diagnostics, AI-driven method optimization, and predictive maintenance to maximize uptime and proactively prevent failures in regulated environments.
• Broader adoption of 1.0 mm and smaller column formats across QC labs to balance throughput with sustainability goals and reduce laboratory consumable costs.

Conclusion

The Nexera X4 is engineered to minimize system-derived peak broadening, deliver highly reproducible ultra-fast gradient performance, and support analytical miniaturization with reduced solvent consumption. Its modular instruments (pump, autosampler, PDA detector, solvent switching/degassing) combined with digital monitoring and MS-optimized flow paths provide a solution targeted at high-throughput pharmaceutical, bioanalytical, and routine QC laboratories seeking to increase productivity without sacrificing data quality.

References

• Shimadzu Corporation. Nexera X4 Ultra High Performance Liquid Chromatograph — Product Document C196-E102, First Edition: March 2026.